Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E de Jonge

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Critical Care Medicine|July 11, 2001
Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulationM Levi, E de Jonge, T van der Poll
Seminars in Thrombosis and Hemostasis|December 12, 2001
Regulatory role of cytokines in disseminated intravascular coagulationT van der Poll, E de Jonge, M Levi
Facts, Views & Vision in Obgyn|October 2, 2024
Transvaginal uterine niche repair: surgical technique and outcomeD Coppenrath, D Timmerman, E De Jonge, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 14, 2003
[The value of the pulmonary-artery catheter: not ruled out, but not proven either]E de Jonge, E J van Lieshout, M B Vroom
Studies in Health Technology and Informatics|August 10, 2012
Consistency of nurses' daily predictions of survival in the intensive careLilian Minne, Dave A Dongelmans, E de Jonge, et al.
Tijdschrift Voor Psychiatrie|May 13, 2009
[Behavioural changes during forensic psychiatric treatment: a multicenter study]E de Jonge, H L I Nijman, S M M Lammers
Seminars in Thrombosis and Hemostasis|December 12, 2001
Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experienceE de Jonge, T van der Poll, J Kesecioglu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1995
Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type IL Fantry, E De Jonge, P G Auwaerter, et al.
Intensive Care Medicine|January 26, 2002
Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjectsE de Jonge, M Levi, H R Büller, et al.
Critical Care Medicine|September 28, 2000
Novel approaches to the management of disseminated intravascular coagulationM Levi, E de Jonge, T van der Poll, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Critical Care Medicine|July 11, 2001
Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulationM Levi, E de Jonge, T van der Poll
Seminars in Thrombosis and Hemostasis|December 12, 2001
Regulatory role of cytokines in disseminated intravascular coagulationT van der Poll, E de Jonge, M Levi
Facts, Views & Vision in Obgyn|October 2, 2024
Transvaginal uterine niche repair: surgical technique and outcomeD Coppenrath, D Timmerman, E De Jonge, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 14, 2003
[The value of the pulmonary-artery catheter: not ruled out, but not proven either]E de Jonge, E J van Lieshout, M B Vroom
Studies in Health Technology and Informatics|August 10, 2012
Consistency of nurses' daily predictions of survival in the intensive careLilian Minne, Dave A Dongelmans, E de Jonge, et al.
Tijdschrift Voor Psychiatrie|May 13, 2009
[Behavioural changes during forensic psychiatric treatment: a multicenter study]E de Jonge, H L I Nijman, S M M Lammers
Seminars in Thrombosis and Hemostasis|December 12, 2001
Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experienceE de Jonge, T van der Poll, J Kesecioglu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1995
Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type IL Fantry, E De Jonge, P G Auwaerter, et al.
Intensive Care Medicine|January 26, 2002
Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjectsE de Jonge, M Levi, H R Büller, et al.
Critical Care Medicine|September 28, 2000
Novel approaches to the management of disseminated intravascular coagulationM Levi, E de Jonge, T van der Poll, et al.
Pageof 13